FDA Approves Avlayah for Hunter Syndrome
WASHINGTON — U.S. regulators have granted accelerated approval to Avlayah, a new treatment aimed at neurologic symptoms in children with Hunter syndrome, a rare inherited disorder. Our curated coverage draws…
Ethical Objective Balanced Sentinel
Where truth stands guard
WASHINGTON — U.S. regulators have granted accelerated approval to Avlayah, a new treatment aimed at neurologic symptoms in children with Hunter syndrome, a rare inherited disorder. Our curated coverage draws…